The USFDA has approved Allergan's Botox (onabotulinumtoxinA) as overactive bladder (OAB) therapy for adults who do not respond to or who cannot tolerate an anticholinergic medication. The approval was based on safety and efficacy data ...
Tags: FDA, Allergan overactive bladder, anticholinergic treatments